← MHRA ALERTS
MHRA (UK) · DRUG SAFETY UPDATE16 June 2026
ACE-inhibitors: Be aware of the distinction between bradykinin- and histamine-mediated angioedema, as treatment strategies differ significantly
What this record is not
Alert details are published by the UK MHRA on GOV.UK; SPEQ surfaces them for reference and is not affiliated with or endorsed by the MHRA. The authoritative notice is on gov.uk.
Alert type
Drug Safety Update
Alert date
16 June 2026
Regulator
MHRA (United Kingdom)
READ THE FULL ALERT
The complete MHRA alert — the affected products, batches, and the action required — is published on GOV.UK. SPEQ surfaces and indexes it for reference; the authoritative notice lives on gov.uk.
View on gov.uk →That is what MHRA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.
Create a free account